New technology for detecting how proteins bind to DNA
Collaborative Research: DMS/NIGMS 2: Novel machine-learning framework for AFMscanner in DNA-protein interaction detection
['FUNDING_R01'] · UNIVERSITY OF GEORGIA · NIH-10932280
This study is working on a new way to use special imaging technology to see how proteins called transcription factors attach to DNA, which could help us better understand gene regulation and its role in diseases.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF GEORGIA (nih funded) |
| Locations | 1 site (ATHENS, UNITED STATES) |
| Trial ID | NIH-10932280 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a novel imaging method using atomic force microscopy (AFM) to detect and quantify how transcription factors (TFs) bind to DNA. By integrating advanced mathematical and statistical techniques with bioengineering, the project aims to create a fully automated system for precise imaging of these interactions. This innovative approach seeks to overcome limitations of traditional methods by enhancing image resolution and automating the search for binding sites. The ultimate goal is to improve our understanding of gene regulation and its implications for various diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with genetic disorders or cancers related to gene regulation.
Not a fit: Patients with conditions unrelated to DNA-protein interactions or gene regulation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to breakthroughs in understanding gene regulation, potentially impacting treatments for genetic disorders and cancers.
How similar studies have performed: While the integration of machine learning with AFM for DNA-protein interaction detection is a novel approach, similar methodologies in other areas of molecular biology have shown promising results.
Where this research is happening
ATHENS, UNITED STATES
- UNIVERSITY OF GEORGIA — ATHENS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ZHONG, WENXUAN — UNIVERSITY OF GEORGIA
- Study coordinator: ZHONG, WENXUAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.